Phage Directory has recently partnered with Phage Australia to help optimize Australia's data-centric standardized approach to personalized phage therapy. Here is a behind-the-scenes look at the genesis of Phage Australia, how the Phage Directory–Phage Australia partnership started, and what it is working toward.
Get full access to this article
View all access options for this article.
References
1.
KhatamiA, LinRC, Petrovic-FabijanA, et al.Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child. EMBO Mol Med. 2021; 13(9):e13936.
2.
Petrovic FabijanA, LinRCY, HoJ, et al.Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol. 2020; 5:465–472. [Epub ahead of print]; DOI: 10.1038/s41564-019-0634-z.
PirnayJP, VerbekenG, CeyssensPJ, et al.The magistral phage. Viruses. 2018; 10(2):64.
9.
TerwilligerAL, Gu LiuC, GreenSI, et al.Tailored antibacterials and innovative laboratories for phage (Φ) research: Personalized infectious disease medicine for the most vulnerable at-risk patients. Phage. 2020; 1(2):66–74.
